| Company/Division name | Fujifilm Diosynth Biotechnologies | 
 | Parent company | Fujifilm Corporation | 
 | Type of work | Manufacturing | 
 | Reshoring category: | Foreign Direct Investment | 
 | Year reshoring announced: | 2022 | 
 | Country(ies) from which reshored: | Japan | 
 | City reshored to: | College Station | 
 | State(s) reshored to: | TX | 
 | If relevant, work nearshored to: | - | 
 | Industry(ies): | Chemicals | 
 | Product(s) reshored | biologics, vaccines, advanced therapies | 
 | What domestic positive factors made reshoring more attractive? | Skilled workforce availability/training |